ZKR Orthopedics Announces First Patella LIFT™ Surgeries on the East Coast at Hospital for Special Surgery in Enrollment of FDA PELICAN Trial
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) — ZKR Orthopedics announced today that the first Patella LIFT™ procedures on the East Coast were successfully performed as part of the PELICAN TRIAL, at the renowned Hospital for Special Surgery (HSS) in... Read More →
Raydiant Oximetry Names Michael Nagel to Lead the Company into its Device Commercialization Stage as CEO
SAN RAMON, CA, UNITED STATES, September 16, 2025 /EINPresswire.com/ — Raydiant Oximetry, Inc., a clinical-stage medical device company developing fetal monitoring innovations using advanced biophotonics and machine learning to improve outcomes during childbirth, today announced the appointment of Michael Nagel... Read More →
SutureTech Announces FDA 510(k) Clearance for RapidFix™, Its All – Suture Staple Device for Soft Tissue Repair
Durham, NC — September 16, 2025 — SutureTech, a surgeon-founded medical device company focused on advancing soft tissue and tendon repair, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for RapidFix™, its flagship device.... Read More →
Neurescue’s resuscitation device nets European approval for non-shockable cardiac arrests
Not all cardiac arrests can be treated with an electric shock. In fact, most of them—about 80%—are ineligible for defibrillation. With a survival rate of about 4%, these deaths continue to number between 7 million and 9 million per year.... Read More →
GE HealthCare inks Icometrix buyout to acquire brain MRI software
The deal includes AI-powered software for detecting known side effects of recently launched Alzheimer’s drugs. Dive Brief: GE HealthCare has struck a deal to buy brain analysis business Icometrix for an undisclosed sum, the companies said Wednesday. Icometrix received 510(k)... Read More →
Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financing to Accelerate Commercialization of Colovac®
Asabys joins SafeHeal’s global investor syndicate, which includes Sofinnova, Solar Eclipse and a Leading Multinational Life Sciences Corporation, bringing additional resources and strategic expertise to advance pivotal U.S. trial and commercial launch of Colovac®, SafeHeal’s breakthrough alternative to temporary stoma... Read More →
PanTher Completes First Cohort in Pancreatic Cancer Phase 1b Trial Ahead of Expectations
– Trial evaluating PTM-101, an absorbable, long-lasting, high-dose chemotherapy patch for non-metastatic pancreatic cancer – – PTM-101 administration in the 200 mg cohort has been completed without dose-limiting toxicity – – First subject enrolled in highest cohort of dose escalation... Read More →
Tasso, Inc. Joint Venture Receives Controlled Medical Device Approval in Japan for Novel Self-Administered Blood Collection Device
Certification clears path in Japan for wider access to preventive medicine, telemedicine, and reduced provider burden SEATTLE – September 9, 2025 – Tasso, Inc., the leading provider of patient-centric, clinical-grade blood collection solutions, today announced that the TS Blood Collection... Read More →
Akeyna’s Smart Needle: Worcester Startup in Auxilium Cohort Targets Safer Injections
WORCESTER, MA-Karen Cronholm, the CEO of Akeyna, Inc., and part of the historic first cohort of Auxilium stops by the Talk of the Commonwealth to tell us about her business and how Auxilium is providing assistance. Cronholm discussed her company’s... Read More →
CHO Plus Obtains U.S. Patent for Improved Production of Proteins Using Engineered Yeast Cells
Cell Engineering Technology Will Increase Recombinant Protein Production for Food Ingredients, Industrial Enzymes, and Other Products SOUTH SAN FRANCISCO, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) — CHO Plus, Inc. (www.CHO-Plus.com), a leading developer of biopharmaceutical manufacturing technology, announced that U.S.... Read More →